Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A review

詳細情報 詳細情報について

• CRID

  1360292620594447744

• DOI

  10.1016/j.ygyno.2021.05.018

• ISSN

  00908258

• Web Site

  https://api.elsevier.com/content/article/PII:S0090825821004248?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0090825821004248?httpAccept=text/plain

• データソース種別

  • Crossref